Partial eNOS deficiency causes spontaneous thrombotic cerebral infarction, amyloid angiopathy and cognitive impairment

Mol Neurodegener. 2015 Jun 24:10:24. doi: 10.1186/s13024-015-0020-0.

Abstract

Background: Cerebral infarction due to thrombosis leads to the most common type of stroke and a likely cause of age-related cognitive decline and dementia. Endothelial nitric oxide synthase (eNOS) generates NO, which plays a crucial role in maintaining vascular function and exerting an antithrombotic action. Reduced eNOS expression and eNOS polymorphisms have been associated with stroke and Alzheimer's disease (AD), the most common type of dementia associated with neurovascular dysfunction. However, direct proof of such association is lacking. Since there are no reports of complete eNOS deficiency in humans, we used heterozygous eNOS(+/-) mice to mimic partial deficiency of eNOS, and determine its impact on cerebrovascular pathology and perfusion of cerebral vessels.

Results: Combining cerebral angiography with immunohistochemistry, we found thrombotic cerebral infarctions in eNOS(+/-) mice as early as 3-6 months of age but not in eNOS(+/+) mice at any age. Remarkably, vascular occlusions in eNOS(+/-) mice were found almost exclusively in three areas: temporoparietal and retrosplenial granular cortexes, and hippocampus this distribution precisely matching the hypoperfused areas identified in preclinical AD patients. Moreover, progressive cerebral amyloid angiopaphy (CAA), blood brain barrier (BBB) breakdown, and cognitive impairment were also detected in aged eNOS(+/-) mice.

Conclusions: These data provide for the first time the evidence that partial eNOS deficiency results in spontaneous thrombotic cerebral infarctions that increase with age, leading to progressive CAA and cognitive impairments. We thus conclude that eNOS(+/-) mouse may represent an ideal model of ischemic stroke to address early and progressive damage in spontaneously-evolving chronic cerebral ischemia and thus, study vascular mechanisms contributing to vascular dementia and AD.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging
  • Animals
  • Blood-Brain Barrier / physiology*
  • Cerebral Amyloid Angiopathy / genetics*
  • Cerebral Amyloid Angiopathy / pathology
  • Cerebral Infarction / enzymology
  • Cerebral Infarction / genetics*
  • Cerebral Infarction / pathology
  • Cerebral Infarction / psychology
  • Cerebrovascular Circulation
  • Cognition Disorders / enzymology
  • Cognition Disorders / genetics*
  • Cognition Disorders / pathology
  • Disease Progression
  • Endothelium, Vascular / physiopathology
  • Gene Expression Regulation
  • Heterozygote
  • Hippocampus / blood supply
  • Hippocampus / enzymology
  • Hippocampus / pathology
  • Maze Learning
  • Memory Disorders / enzymology
  • Memory Disorders / genetics
  • Memory Disorders / pathology
  • Mice
  • Mice, Neurologic Mutants
  • Nerve Tissue Proteins / biosynthesis
  • Nerve Tissue Proteins / genetics
  • Nitric Oxide Synthase Type III / deficiency
  • Nitric Oxide Synthase Type III / genetics
  • Nitric Oxide Synthase Type III / physiology*
  • Organ Specificity
  • Parietal Lobe / blood supply
  • Parietal Lobe / enzymology
  • Parietal Lobe / pathology
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Temporal Lobe / blood supply
  • Temporal Lobe / enzymology
  • Temporal Lobe / pathology

Substances

  • Nerve Tissue Proteins
  • RNA, Messenger
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse